▲ Peaking
Health
🔮 fades ✓
GLP-1 weight-loss drugs show promise for sleep apnea
Recent coverage highlights a potential new therapeutic benefit for GLP-1 weight-loss drugs regarding sleep apnea.
Weight-Loss Drugs
20 trends tracked about this subject — the full history, oldest to newest below.
↑ Rising
Health
🔮 fades ✗
Cravings ‘like heroin withdrawal’: what happens when weight-loss drugs don’t work?
Concerns grow over the efficacy of weight-loss injections and the severe withdrawal-like cravings some patients experience when the drugs fail.
◼ Archived
Health
🔮 fades ✓
More children under 12 in US are being prescribed weight-loss drugs, study finds
Recent studies reveal a surge in US children under 12 being prescribed weight-loss drugs like GLP-1.
▲ Peaking
Health
🔮 fades ✓
Scientists Flag Shocking New Concern for Men on GLP-1 Drugs
A new scientific study has identified a genetic link between the use of GLP-1 weight-loss medications and increased hair loss in men.
◼ Archived
Health
🔮 fades ✓
Weight loss drugs could see men losing more than just fat
New reports suggest popular GLP‑1 weight‑loss drugs may trigger male pattern baldness, sparking medical and public‑interest scrutiny.
◼ Archived
Health
🔮 fades ✓
GLP-1 weight loss drugs effective even at low starter doses
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Ozempic may help people with serious mental health condition: study
Ozempic, a popular weight‑loss drug, is now being linked to benefits for serious mental illnesses such as bipolar disorder.
◼ Archived
Health
🔮 fades ✗
Ozempic is not just a weight-loss story anymore
Recent discussions highlight a shift in the narrative surrounding weight-loss drugs, focusing on gender dynamics and the desire for medical privacy.
◼ Archived
Health
🔮 fades ✗
Coroner links teenage student’s death to weight-loss drug Mounjaro
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Starbucks is ending GLP-1 coverage for weight loss as employer costs climb
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
Pharmacists Warn About Diet on Weight Loss Drugs
Pharmacists and health experts are urging GLP-1 weight loss medication users to prioritize specific nutritional strategies to mitigate side effects.
◼ Archived
Health
🔮 fades
Hair loss with GLP-1 drugs is rare, but real, studies find
New research suggests a link between GLP-1 weight-loss medications and an increased risk of hair loss, though the occurrence is described as rare.
◼ Archived
Health
🔮 fades
Weight loss drugs linked to increased risk of hair loss, researchers say
New research links GLP-1 weight-loss medications like Ozempic and Mounjaro to an increased risk of hair loss in patients.
◼ Archived
Business
🔮 holds
Novo sues Lilly, claiming misleading ads in weight-loss drug battle
Novo Nordisk has filed a lawsuit against Eli Lilly over allegations of deceptive and misleading advertising regarding GLP-1 weight-loss drugs.
◼ Archived
Health
🔮 fades
GLP-1’s Reduce Binge Eating Symptoms
Emerging research suggests GLP-1 receptor agonists may provide a promising treatment for binge eating disorder and emotional eating symptoms.
◼ Archived
Business
🔮 fades
What older adults need to know before taking a GLP-1 medication to lose weight
Recent reporting examines why Medicare policy fails to transform the market prospects for weight-loss drug manufacturers.
◼ Archived
Health
🔮 fades
As weight loss drugs like Ozempic spread, Louisiana doctors, researchers help answer big questions
GLP-1 weight‑loss drugs spark a wave of research, clinical guidance and market buzz as they expand beyond obesity treatment.
◼ Archived
Health
🔮 fades
GLP-1 drugs linked to major drop in pancreatic, colorectal cancer risk
11 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
Weight loss drugs slash risk of 4 types of cancer by 50% or more, study finds
New study data indicates that GLP-1 weight loss medications are associated with a significant reduction in the risk of developing four specific cancer types.
◼ Archived
Health
🔮 fades
Ozempic Users Are Skimping Out on Exercise, Study Finds
New research indicates that patients taking GLP-1 weight loss drugs are reducing their physical activity levels.